• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

达到临界点:良性前列腺增生患者生活质量和治疗决策的定性探讨。

Reaching a Tipping Point: A Qualitative Exploration of Quality of Life and Treatment Decision-Making in People Living With Benign Prostatic Hyperplasia.

机构信息

Department of Psychology, 405729University of Winchester, Winchester, UK.

Urology Department, 9946Hampshire Hospitals NHS Foundation Trust, Winchester, UK.

出版信息

Qual Health Res. 2022 Nov;32(13):1979-1992. doi: 10.1177/10497323221129262. Epub 2022 Sep 26.

DOI:10.1177/10497323221129262
PMID:36154347
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9629511/
Abstract

Benign prostatic hyperplasia (BPH) is a common condition amongst older men and is associated with lower urinary tract symptoms and erectile dysfunction; these symptoms can be burdensome and negatively affect quality of life. Various surgical and pharmaceutical treatment options exist but there is a paucity of qualitative research exploring men's decision-making when seeking BPH treatment. This study qualitatively explored men's experience of living with BPH and seeking treatment for BPH. Twenty men (aged 52-75) were recruited from outpatient urology clinics at a hospital trust in Southern England. Data were collected using semi-structured interviews (via video or telephone call) and were audio-recorded; transcripts were analysed using thematic analysis. Four themes were generated: 'Impacts are about more than just physical symptoms', 'The path towards treatment', 'The process of information gathering' and 'Navigating hopes, fears and uncertainty'. Results indicate most men appear to seek treatment for BPH following a gradual, and sometimes lengthy, period of deterioration in symptoms; for some men, however, treatment seeking follows an acute episode of sudden or severe symptoms. The decision to proceed with surgical or minimally invasive treatment options appears to be dependent on men reaching a tipping point; they no longer perceive their symptoms as tolerable and feel their ability to cope with symptoms is reduced. Men each bring their own set of concerns and preferences about side effects and risk-benefit profiles of different treatments. Clinicians need to be sensitive to these individual differences and incorporate them into shared decision-making for choosing between treatment options for BPH.

摘要

良性前列腺增生(BPH)是老年男性常见的疾病,与下尿路症状和勃起功能障碍有关;这些症状可能会带来负担,并对生活质量产生负面影响。有多种手术和药物治疗选择,但缺乏定性研究来探讨男性在寻求 BPH 治疗时的决策过程。本研究定性探讨了男性患有 BPH 并寻求 BPH 治疗的体验。从英格兰南部一家医院信托的门诊泌尿科诊所招募了 20 名年龄在 52-75 岁的男性。使用半结构化访谈(通过视频或电话)收集数据,并进行音频记录;使用主题分析对转录本进行分析。生成了四个主题:“影响不仅仅是身体症状”、“治疗之路”、“信息收集过程”和“应对希望、恐惧和不确定性”。结果表明,大多数男性似乎在症状逐渐恶化,有时甚至是漫长的一段时间后,才会寻求 BPH 的治疗;然而,对于一些男性来说,治疗的寻求是在突然或严重症状的急性发作之后。选择接受手术或微创治疗方案的决定似乎取决于男性是否达到了一个临界点;他们不再认为自己的症状可以忍受,并且感到自己应对症状的能力下降。男性对不同治疗方法的副作用和风险效益特征都有自己的一套担忧和偏好。临床医生需要对这些个体差异敏感,并将其纳入选择 BPH 治疗方案的共同决策中。

相似文献

1
Reaching a Tipping Point: A Qualitative Exploration of Quality of Life and Treatment Decision-Making in People Living With Benign Prostatic Hyperplasia.达到临界点:良性前列腺增生患者生活质量和治疗决策的定性探讨。
Qual Health Res. 2022 Nov;32(13):1979-1992. doi: 10.1177/10497323221129262. Epub 2022 Sep 26.
2
The Risk of Sexual Dysfunction and Effectiveness of Treatment of Benign Prostatic Hyperplasia With Severe Lower Urinary Tract Dysfunction With Combination of Dutasteride and Solifenacin.良性前列腺增生伴严重下尿路功能障碍患者联合使用度他雄胺和索利那新治疗的性功能障碍风险及疗效。
J Sex Med. 2018 Nov;15(11):1579-1590. doi: 10.1016/j.jsxm.2018.09.011.
3
[PDE5: A new therapeutic target for lower urinary tract symptoms/ benign prostatic hyperplasia combined with erectile dysfunction].[磷酸二酯酶5:下尿路症状/良性前列腺增生合并勃起功能障碍的新治疗靶点]
Zhonghua Nan Ke Xue. 2018 Apr;24(4):355-359.
4
Effectiveness of tadalafil 5 mg once daily in the treatment of men with lower urinary tract symptoms suggestive to benign prostatic hyperplasia with or without erectile dysfunction: results from naturalistic observational TadaLutsEd study.每日一次坦索罗辛 5 毫克治疗伴或不伴勃起功能障碍的下尿路症状提示良性前列腺增生症男性的疗效:自然观察性 TadaLutsEd 研究结果。
J Sex Med. 2014 Feb;11(2):498-505. doi: 10.1111/jsm.12386. Epub 2013 Nov 13.
5
Tadalafil - a therapeutic option in the management of BPH-LUTS.他达拉非——治疗良性前列腺增生相关下尿路症状的一种选择。
Int J Clin Pract. 2014 Jan;68(1):94-103. doi: 10.1111/ijcp.12305.
6
Sexual function in men with lower urinary tract symptoms and prostatic enlargement secondary to benign prostatic hyperplasia: results of a 6-month, randomized, double-blind, placebo-controlled study of tadalafil coadministered with finasteride.良性前列腺增生继发下尿路症状和前列腺肿大男性的性功能:他达拉非与非那雄胺联合使用的6个月随机双盲安慰剂对照研究结果
J Sex Med. 2015 Jan;12(1):129-38. doi: 10.1111/jsm.12714. Epub 2014 Oct 29.
7
Direct effects of tadalafil on lower urinary tract symptoms versus indirect effects mediated through erectile dysfunction symptom improvement: integrated data analyses from 4 placebo controlled clinical studies.他达拉非对下尿路症状的直接作用与通过改善勃起功能障碍症状介导的间接作用:4 项安慰剂对照临床研究的综合数据分析。
J Urol. 2014 Feb;191(2):405-11. doi: 10.1016/j.juro.2013.09.057. Epub 2013 Oct 1.
8
Tadalafil once daily in the treatment of lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) in men without erectile dysfunction.他达拉非每日一次治疗男性下尿路症状(LUTS)合并良性前列腺增生(BPH)而无勃起功能障碍。
BJU Int. 2013 Nov;112(7):990-7. doi: 10.1111/bju.12251. Epub 2013 Aug 13.
9
Effects of tadalafil on lower urinary tract symptoms secondary to benign prostatic hyperplasia and on erectile dysfunction in sexually active men with both conditions: analyses of pooled data from four randomized, placebo-controlled tadalafil clinical studies.他达拉非对良性前列腺增生继发的下尿路症状及对同时患有这两种病症的性活跃男性勃起功能障碍的影响:来自四项随机、安慰剂对照他达拉非临床研究的汇总数据分析
J Sex Med. 2013 Aug;10(8):2044-52. doi: 10.1111/jsm.12212. Epub 2013 Jun 19.
10
Erectile dysfunction and lower urinary tract symptoms associated with benign prostatic hyperplasia (LUTS/BPH) combined responders to tadalafil after 12 weeks of treatment.勃起功能障碍与良性前列腺增生相关的下尿路症状(LUTS/BPH)在接受他达拉非治疗12周后联合有效。
BJU Int. 2016 Jul;118(1):153-60. doi: 10.1111/bju.13406. Epub 2016 Feb 11.

引用本文的文献

1
Empowering patient choice: a systematic review of decision aids for benign prostatic hyperplasia.增强患者选择权:对良性前列腺增生症决策辅助工具的系统评价
BJU Int. 2025 Sep;136(3):359-371. doi: 10.1111/bju.16797. Epub 2025 May 27.
2
Cancers and erectile dysfunction: a Mendelian randomization study.癌症与勃起功能障碍:孟德尔随机化研究。
Front Endocrinol (Lausanne). 2024 Nov 6;15:1417830. doi: 10.3389/fendo.2024.1417830. eCollection 2024.
3
A real-world evidence study of interhospital variability in the surgical treatment of patients with benign prostatic hyperplasia: the REVALURO study.良性前列腺增生患者外科治疗医院间差异的真实世界证据研究:REVALURO研究
Int Urol Nephrol. 2025 Mar;57(3):775-784. doi: 10.1007/s11255-024-04239-7. Epub 2024 Oct 29.
4
Treatment Algorithm for Management of Benign Prostatic Obstruction: An Overview of Current Techniques.良性前列腺梗阻的治疗算法:当前技术概述
Life (Basel). 2023 Oct 18;13(10):2077. doi: 10.3390/life13102077.

本文引用的文献

1
Sample sizes for saturation in qualitative research: A systematic review of empirical tests.定性研究中饱和度的样本量:实证检验的系统综述。
Soc Sci Med. 2022 Jan;292:114523. doi: 10.1016/j.socscimed.2021.114523. Epub 2021 Nov 2.
2
A Systematic Review of Patients' Values, Preferences, and Expectations for the Diagnosis and Treatment of Male Lower Urinary Tract Symptoms.男性下尿路症状的诊断和治疗中患者的价值观、偏好和期望的系统评价。
Eur Urol. 2021 Jun;79(6):796-809. doi: 10.1016/j.eururo.2020.12.019. Epub 2021 Jan 15.
3
The Balance of Patient Involvement: Patients' and Health Professionals' Perspectives on Decision-Making in the Treatment of Advanced Prostate Cancer.患者参与的平衡:晚期前列腺癌治疗中决策的患者和卫生专业人员观点。
Qual Health Res. 2021 Jan;31(1):29-40. doi: 10.1177/1049732320962759. Epub 2020 Oct 16.
4
Treatment decision-making among men with lower urinary tract symptoms: A qualitative study of men's experiences with recommendations for patient-centred practice.男性下尿路症状治疗决策:一项关于男性接受以患者为中心实践建议的经验的定性研究。
Neurourol Urodyn. 2021 Jan;40(1):201-210. doi: 10.1002/nau.24533. Epub 2020 Oct 14.
5
Patient Perspectives on Benign Prostatic Hyperplasia Surgery: A Focus on Sexual Health.患者对良性前列腺增生症手术的看法:关注性健康。
J Sex Med. 2020 Oct;17(10):2108-2112. doi: 10.1016/j.jsxm.2020.07.006. Epub 2020 Aug 6.
6
Treatment Preferences of Patients With Benign Prostatic Hyperplasia Before and After Using a Web-based Decision Aid.良性前列腺增生患者在使用基于网络的决策辅助工具前后的治疗偏好。
Urology. 2020 Mar;137:138-145. doi: 10.1016/j.urology.2019.12.026. Epub 2019 Dec 30.
7
Incidence of Nocturia in Men with Lower Urinary Tract Symptoms Associated with Benign Prostatic Enlargement and Outcomes After Medical Treatment: Results from the Evolution European Association of Urology Research Foundation Prospective Multinational Registry.良性前列腺增生相关下尿路症状男性夜尿症的发生率和药物治疗后的结局:来自欧洲泌尿外科学会研究基金会进化前瞻性多国注册研究的结果。
Eur Urol Focus. 2021 Jan;7(1):178-185. doi: 10.1016/j.euf.2019.07.003. Epub 2019 Jul 23.
8
Effectiveness of a web-based treatment decision aid for men with lower urinary tract symptoms due to benign prostatic hyperplasia.基于网络的治疗决策辅助工具对良性前列腺增生所致下尿路症状男性患者的疗效。
BJU Int. 2019 Jul;124(1):124-133. doi: 10.1111/bju.14646. Epub 2019 Mar 4.
9
Do patients have to choose between ejaculation and miction? A systematic review about ejaculation preservation technics for benign prostatic obstruction surgical treatment.患者是否必须在射精和排尿之间做出选择?良性前列腺梗阻手术治疗中保留射精技术的系统评价。
World J Urol. 2019 Feb;37(2):299-308. doi: 10.1007/s00345-018-2368-6. Epub 2018 Jul 2.
10
Enucleation, Vaporization, and Resection: How To Choose the Best Surgical Treatment Option for a Patient with Male Lower Urinary Tract Symptoms.去势、汽化和切除术:如何为男性下尿路症状患者选择最佳的手术治疗方案。
Eur Urol Focus. 2018 Jan;4(1):8-10. doi: 10.1016/j.euf.2018.04.020. Epub 2018 May 10.